Factors associated with survival for patients with glioblastoma with poor pre-operative functional status

Kaisorn L. Chaichana, Juan Carlos Martinez-Gutierrez, Rafael De La Garza-Ramos, Jon David Weingart, Alessandro Olivi, Gary L Gallia, Michael Lim, Henry Brem, Alfredo Quinones-Hinojosa

Research output: Contribution to journalArticle

Abstract

Patients with glioblastoma (GB) are known to have poor prognoses, and among these patients, those with poor neurological function have an even poorer prognosis. Consequently, aggressive surgeries and adjuvant therapies are often withheld because of this dismal outlook. The effects of aggressive therapies in this small subset of patients remain unknown. The goal of this study was to evaluate outcomes and factors associated with survival for poor functioning patients who underwent aggressive resection of their GB. Adult patients who underwent surgical resection of an intracranial primary GB at an academic tertiary-care institution between 1997 and 2007 were retrospectively reviewed. Patients with a Karnofsky Performance Scale (KPS) score of ≤60 were included. A total of 100 patients with primary GB met the inclusion criteria. The average age (±standard deviation) and KPS score of this cohort were 54 ± 15 years and 53 ± 12, respectively. No patient (0%) experienced perioperative mortality, and 0 (0%), 10(10%), and 3 (3%) of patients incurred a new or increasing language, motor, and visual deficit, respectively. At last follow-up, 88 (88%) patients died with a median survival of 6.6 months. The factors associated with improved survival were age 2 cm (p = 0.01), radical tumor resection (p = 0.01), and temozolomide (p = 0.001). This study identifies a subset of patients with poor functional status who may benefit from aggressive surgical resection.

Original languageEnglish (US)
Pages (from-to)818-823
Number of pages6
JournalJournal of Clinical Neuroscience
Volume20
Issue number6
DOIs
StatePublished - Jun 2013

Fingerprint

Glioblastoma
Survival
Karnofsky Performance Status
temozolomide
Tertiary Healthcare
Language
Mortality

Keywords

  • Glioblastoma
  • Karnofsky performance scale score
  • Outcomes
  • Poor neurological status
  • Survival

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Physiology (medical)
  • Medicine(all)

Cite this

Factors associated with survival for patients with glioblastoma with poor pre-operative functional status. / Chaichana, Kaisorn L.; Martinez-Gutierrez, Juan Carlos; De La Garza-Ramos, Rafael; Weingart, Jon David; Olivi, Alessandro; Gallia, Gary L; Lim, Michael; Brem, Henry; Quinones-Hinojosa, Alfredo.

In: Journal of Clinical Neuroscience, Vol. 20, No. 6, 06.2013, p. 818-823.

Research output: Contribution to journalArticle

Chaichana, Kaisorn L. ; Martinez-Gutierrez, Juan Carlos ; De La Garza-Ramos, Rafael ; Weingart, Jon David ; Olivi, Alessandro ; Gallia, Gary L ; Lim, Michael ; Brem, Henry ; Quinones-Hinojosa, Alfredo. / Factors associated with survival for patients with glioblastoma with poor pre-operative functional status. In: Journal of Clinical Neuroscience. 2013 ; Vol. 20, No. 6. pp. 818-823.
@article{e6f55d0911ae465d80b47dce905808fe,
title = "Factors associated with survival for patients with glioblastoma with poor pre-operative functional status",
abstract = "Patients with glioblastoma (GB) are known to have poor prognoses, and among these patients, those with poor neurological function have an even poorer prognosis. Consequently, aggressive surgeries and adjuvant therapies are often withheld because of this dismal outlook. The effects of aggressive therapies in this small subset of patients remain unknown. The goal of this study was to evaluate outcomes and factors associated with survival for poor functioning patients who underwent aggressive resection of their GB. Adult patients who underwent surgical resection of an intracranial primary GB at an academic tertiary-care institution between 1997 and 2007 were retrospectively reviewed. Patients with a Karnofsky Performance Scale (KPS) score of ≤60 were included. A total of 100 patients with primary GB met the inclusion criteria. The average age (±standard deviation) and KPS score of this cohort were 54 ± 15 years and 53 ± 12, respectively. No patient (0{\%}) experienced perioperative mortality, and 0 (0{\%}), 10(10{\%}), and 3 (3{\%}) of patients incurred a new or increasing language, motor, and visual deficit, respectively. At last follow-up, 88 (88{\%}) patients died with a median survival of 6.6 months. The factors associated with improved survival were age 2 cm (p = 0.01), radical tumor resection (p = 0.01), and temozolomide (p = 0.001). This study identifies a subset of patients with poor functional status who may benefit from aggressive surgical resection.",
keywords = "Glioblastoma, Karnofsky performance scale score, Outcomes, Poor neurological status, Survival",
author = "Chaichana, {Kaisorn L.} and Martinez-Gutierrez, {Juan Carlos} and {De La Garza-Ramos}, Rafael and Weingart, {Jon David} and Alessandro Olivi and Gallia, {Gary L} and Michael Lim and Henry Brem and Alfredo Quinones-Hinojosa",
year = "2013",
month = "6",
doi = "10.1016/j.jocn.2012.07.016",
language = "English (US)",
volume = "20",
pages = "818--823",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - Factors associated with survival for patients with glioblastoma with poor pre-operative functional status

AU - Chaichana, Kaisorn L.

AU - Martinez-Gutierrez, Juan Carlos

AU - De La Garza-Ramos, Rafael

AU - Weingart, Jon David

AU - Olivi, Alessandro

AU - Gallia, Gary L

AU - Lim, Michael

AU - Brem, Henry

AU - Quinones-Hinojosa, Alfredo

PY - 2013/6

Y1 - 2013/6

N2 - Patients with glioblastoma (GB) are known to have poor prognoses, and among these patients, those with poor neurological function have an even poorer prognosis. Consequently, aggressive surgeries and adjuvant therapies are often withheld because of this dismal outlook. The effects of aggressive therapies in this small subset of patients remain unknown. The goal of this study was to evaluate outcomes and factors associated with survival for poor functioning patients who underwent aggressive resection of their GB. Adult patients who underwent surgical resection of an intracranial primary GB at an academic tertiary-care institution between 1997 and 2007 were retrospectively reviewed. Patients with a Karnofsky Performance Scale (KPS) score of ≤60 were included. A total of 100 patients with primary GB met the inclusion criteria. The average age (±standard deviation) and KPS score of this cohort were 54 ± 15 years and 53 ± 12, respectively. No patient (0%) experienced perioperative mortality, and 0 (0%), 10(10%), and 3 (3%) of patients incurred a new or increasing language, motor, and visual deficit, respectively. At last follow-up, 88 (88%) patients died with a median survival of 6.6 months. The factors associated with improved survival were age 2 cm (p = 0.01), radical tumor resection (p = 0.01), and temozolomide (p = 0.001). This study identifies a subset of patients with poor functional status who may benefit from aggressive surgical resection.

AB - Patients with glioblastoma (GB) are known to have poor prognoses, and among these patients, those with poor neurological function have an even poorer prognosis. Consequently, aggressive surgeries and adjuvant therapies are often withheld because of this dismal outlook. The effects of aggressive therapies in this small subset of patients remain unknown. The goal of this study was to evaluate outcomes and factors associated with survival for poor functioning patients who underwent aggressive resection of their GB. Adult patients who underwent surgical resection of an intracranial primary GB at an academic tertiary-care institution between 1997 and 2007 were retrospectively reviewed. Patients with a Karnofsky Performance Scale (KPS) score of ≤60 were included. A total of 100 patients with primary GB met the inclusion criteria. The average age (±standard deviation) and KPS score of this cohort were 54 ± 15 years and 53 ± 12, respectively. No patient (0%) experienced perioperative mortality, and 0 (0%), 10(10%), and 3 (3%) of patients incurred a new or increasing language, motor, and visual deficit, respectively. At last follow-up, 88 (88%) patients died with a median survival of 6.6 months. The factors associated with improved survival were age 2 cm (p = 0.01), radical tumor resection (p = 0.01), and temozolomide (p = 0.001). This study identifies a subset of patients with poor functional status who may benefit from aggressive surgical resection.

KW - Glioblastoma

KW - Karnofsky performance scale score

KW - Outcomes

KW - Poor neurological status

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84891866212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891866212&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2012.07.016

DO - 10.1016/j.jocn.2012.07.016

M3 - Article

C2 - 23639620

AN - SCOPUS:84891866212

VL - 20

SP - 818

EP - 823

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

IS - 6

ER -